[Correspondence] The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy

Alan Pollack and colleagues1 suggest improved freedom from progression and reduced distant metastasis for patients with prostate cancer who are treated with salvage prostate bed radiotherapy (PBRT) and pelvic lymph node radiotherapy (PLNRT) combined with short-term androgen deprivation therapy (ADT; trial group 3) when compared with treatment with PBRT alone (group 1) or PBRT combined with short-term ADT (group 2). We commend the investigators for completing this important clinical multicentre trial.